| 1 |
34970856 | The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID-19: A meta-analysis of randomized trials. | 2022 Feb |
2 |
| 2 |
35046517 | Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review. | 2022 Jan 19 |
1 |
| 3 |
35113170 | Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation. | 2022 Mar |
3 |
| 4 |
35178861 | Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis. | 2022 Apr |
5 |
| 5 |
33337127 | An update on the pathophysiology of acute and recurrent pericarditis. | 2021 Sep |
1 |
| 6 |
33968934 | Colchicine Blocks Tubulin Heterodimer Recycling by Tubulin Cofactors TBCA, TBCB, and TBCE. | 2021 |
1 |
| 7 |
34312998 | Anti-inflammatory mechanisms and research progress of colchicine in atherosclerotic therapy. | 2021 Sep |
1 |
| 8 |
34492522 | Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy. | 2021 Oct |
5 |
| 9 |
34599390 | Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease. | 2021 Oct 1 |
1 |
| 10 |
34650351 | Anti-inflammatory therapy in ischaemic heart disease: from canakinumab to colchicine. | 2021 Oct |
1 |
| 11 |
34906598 | Targeting the NLRP3 inflammasome in cardiovascular diseases. | 2021 Dec 11 |
1 |
| 12 |
32611559 | Colchicine for acute and chronic coronary syndromes. | 2020 Oct |
1 |
| 13 |
32733639 | Colchicine Alleviates Cholesterol Crystal-Induced Endothelial Cell Pyroptosis through Activating AMPK/SIRT1 Pathway. | 2020 |
1 |
| 14 |
32808940 | The therapeutic potential of colchicine in the complications of COVID19. Could the immunometabolic properties of an old and cheap drug help? | 2020 Sep |
1 |
| 15 |
33110739 | Immunomodulatory Therapies for COVID-19 in Solid Organ Transplant Recipients. | 2020 |
1 |
| 16 |
30591286 | Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview. | 2019 Jan |
1 |
| 17 |
31522718 | Colchicine inhibits endothelial inflammation via NLRP3/CRP pathway. | 2019 Nov 1 |
1 |
| 18 |
31558729 | Gout. | 2019 Sep 26 |
1 |
| 19 |
29232311 | Lithium + Colchicine: A Potential Strategy to Reduce Pro-inflammatory Effects of Lithium Treatment. | 2018 Feb |
1 |
| 20 |
29352570 | The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation. | 2018 Feb |
1 |
| 21 |
29904810 | Colchicine in Pericardial Disease: from the Underlying Biology and Clinical Benefits to the Drug-Drug Interactions in Cardiovascular Medicine. | 2018 Jun 14 |
1 |
| 22 |
27129183 | Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation. | 2016 Jul 1 |
1 |
| 23 |
27241260 | Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation. | 2016 Jul |
2 |
| 24 |
25864748 | Transcriptional activity of neutrophils exposed to high doses of colchicine: short communication. | 2015 Jan-Mar |
2 |
| 25 |
26304941 | Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome. | 2015 Aug 24 |
1 |
| 26 |
22870500 | Treatment and management of pseudogout: insights for the clinician. | 2012 Apr |
2 |
| 27 |
18973929 | Colchicine update: 2008. | 2009 Jun |
1 |